MEDIROM Healthcare Techno... (MRM)
MEDIROM Healthcare Statistics
Share Statistics
MEDIROM Healthcare has 4.94M shares outstanding. The number of shares has increased by 1.14% in one year.
Shares Outstanding | 4.94M |
Shares Change (YoY) | 1.14% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 2.36% |
Shares Floating | 2.27M |
Failed to Deliver (FTD) Shares | 63.2K |
FTD / Avg. Volume | 3.76% |
Short Selling Information
The latest short interest is 43.49K, so 0.88% of the outstanding shares have been sold short.
Short Interest | 43.49K |
Short % of Shares Out | 0.88% |
Short % of Float | 1.92% |
Short Ratio (days to cover) | 1.38 |
Valuation Ratios
The PE ratio is 36.2 and the forward PE ratio is null. MEDIROM Healthcare's PEG ratio is -1.34.
PE Ratio | 36.2 |
Forward PE | n/a |
PS Ratio | 0.61 |
Forward PS | 0 |
PB Ratio | 19.75 |
P/FCF Ratio | -5.43 |
PEG Ratio | -1.34 |
Enterprise Valuation
MEDIROM Healthcare has an Enterprise Value (EV) of 7.71B.
EV / Sales | 1.13 |
EV / EBITDA | 24.86 |
EV / EBIT | -12.2 |
EV / FCF | -10.04 |
Financial Position
The company has a current ratio of 0.49, with a Debt / Equity ratio of 17.31.
Current Ratio | 0.49 |
Quick Ratio | 0.45 |
Debt / Equity | 17.31 |
Debt / EBITDA | 11.77 |
Debt / FCF | -4.75 |
Interest Coverage | -10.62 |
Financial Efficiency
Return on Equity is 54.56% and Return on Invested Capital is -47.99%.
Return on Equity | 54.56% |
Return on Assets | 1.68% |
Return on Invested Capital | -47.99% |
Revenue Per Employee | $15.88M |
Profits Per Employee | $267.56K |
Employee Count | 430 |
Asset Turnover | 1 |
Inventory Turnover | 37.57 |
Taxes
Income Tax | -94.43M |
Effective Tax Rate | -457.89% |
Stock Price Statistics
The stock price has increased by -85.48% in the last 52 weeks. The beta is 0.65, so MEDIROM Healthcare's price volatility has been higher than the market average.
Beta | 0.65 |
52-Week Price Change | -85.48% |
50-Day Moving Average | 0.7 |
200-Day Moving Average | 2.3 |
Relative Strength Index (RSI) | 60.89 |
Average Volume (20 Days) | 1.68M |
Income Statement
In the last 12 months, MEDIROM Healthcare had revenue of 6.83B and earned 115.05M in profits. Earnings per share was 22.27.
Revenue | 6.83B |
Gross Profit | 1.57B |
Operating Income | -391.58M |
Net Income | 115.05M |
EBITDA | 310.08M |
EBIT | 57.49M |
Earnings Per Share (EPS) | 22.27 |
Balance Sheet
The company has 106.35M in cash and 3.65B in debt, giving a net cash position of -3.54B.
Cash & Cash Equivalents | 106.35M |
Total Debt | 3.65B |
Net Cash | -3.54B |
Retained Earnings | 80.28M |
Total Assets | 5.83B |
Working Capital | -2.19B |
Cash Flow
In the last 12 months, operating cash flow was -631.74M and capital expenditures -135.84M, giving a free cash flow of -767.58M.
Operating Cash Flow | -631.74M |
Capital Expenditures | -135.84M |
Free Cash Flow | -767.58M |
FCF Per Share | -148.59 |
Margins
Gross margin is 22.98%, with operating and profit margins of -5.73% and 1.68%.
Gross Margin | 22.98% |
Operating Margin | -5.73% |
Pretax Margin | 0.3% |
Profit Margin | 1.68% |
EBITDA Margin | 4.54% |
EBIT Margin | -5.73% |
FCF Margin | -11.24% |
Dividends & Yields
MRM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 2.76% |
FCF Yield | -18.43% |
Analyst Forecast
Currently there are no analyst rating for MRM.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 1.41 |
Piotroski F-Score | 1 |